Skip to main content
. 2020 Jul 2;219:222–230. doi: 10.1016/j.ajo.2020.06.028

Table 5.

Profits Generated Based on Drug Use in the Different Clinic Models

Model Cost Per Encounter
Reimbursement Per Encounter
Net Profit Per Encounter
Bevacizumab Aflibercept Bevacizumab Aflibercept Bevacizumab Aflibercept
With VA and DFE encounter $85.55 $1787.58 $284.32 $2124.78 $198.77 $337.20
OCT-only encounter $68.85 $1779.88 $193.93 $2034.39 $125.08 $263.51

DFE = dilated fundus examination; OCT = optical coherence tomography; VA = visual acuity.